Bilimoria KY, Bentrem DJ, Hansen NM, Bethke KP, Rademaker AW, Ko CY, et al. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2009;27:2946–53. https://doi.org/10.1200/JCO.2008.19.5750.

Article  Google Scholar 

Samiei S, van Nijnatten TJA, de Munck L, Keymeulen KBMI, Simons JM, Kooreman LFS, et al. Correlation between pathologic complete response in the breast and absence of axillary lymph node metastases after neoadjuvant systemic therapy. Ann Surg. 2020;271:574–80. https://doi.org/10.1097/SLA.0000000000003126.

Article  PubMed  Google Scholar 

Samiei S, Simons JM, Engelen SME, Beets-Tan RGH, Classe J-M, Smidt ML. Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease. JAMA Surg. 2021;156:e210891. https://doi.org/10.1001/jamasurg.2021.0891.

Article  PubMed  PubMed Central  Google Scholar 

Simons JM, van Nijnatten TJA, van der Pol CC, Luiten EJT, Koppert LB, Smidt ML. Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis. Ann Surg. 2019;269:432–42. https://doi.org/10.1097/SLA.0000000000003075.

Article  PubMed  Google Scholar 

Boughey JC, Suman VJ, Mittendorf EA, Ahrendt GM, Wilke LG, Taback B, et al. Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. JAMA. 2013;310:1455–61. https://doi.org/10.1001/jama.2013.278932.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McLaughlin SA, Wright MJ, Morris KT, Giron GL, Sampson MR, Brockway JP, et al. Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:5213–9. https://doi.org/10.1200/JCO.2008.16.3725.

Article  Google Scholar 

Crane-Okada R, Wascher RA, Elashoff D, Giuliano AE. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol. 2008;15:1996–2005. https://doi.org/10.1245/s10434-008-9909-y.

Article  PubMed  Google Scholar 

Suami H, Chang DW. Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg. 2010;126:1853–63. https://doi.org/10.1097/PRS.0b013e3181f44658.

Article  CAS  PubMed  Google Scholar 

Senkus E, Cardoso MJ, Kaidar-Person O, Łacko A, Meattini I, Poortmans P. De-escalation of axillary irradiation for early breast cancer - Has the time come? Cancer Treat Rev. 2021;101:102297. https://doi.org/10.1016/j.ctrv.2021.102297.

Article  PubMed  Google Scholar 

Guo R, Su Y, Si J, Xue J, Yang B, Zhang Q, et al. A nomogram for predicting axillary pathologic complete response in hormone receptor-positive breast cancer with cytologically proven axillary lymph node metastases. Cancer. 2020;126(Suppl 16):3819–29. https://doi.org/10.1002/cncr.32830.

Article  CAS  PubMed  Google Scholar 

Vila J, Mittendorf EA, Farante G, Bassett RL, Veronesi P, Galimberti V, et al. Nomograms for predicting axillary response to neoadjuvant chemotherapy in clinically node-positive patients with breast cancer. Ann Surg Oncol. 2016;23:3501–9. https://doi.org/10.1245/s10434-016-5277-1.

Article  PubMed  Google Scholar 

Boughey JC, Ballman KV, Hunt KK, McCall LM, Mittendorf EA, Ahrendt GM, et al. Axillary ultrasound after neoadjuvant chemotherapy and its impact on sentinel lymph node surgery: results from the American College of Surgeons Oncology Group Z1071 Trial (Alliance). J Clin Oncol Off J Am Soc Clin Oncol. 2015;33:3386–93. https://doi.org/10.1200/JCO.2014.57.8401.

Article  CAS  Google Scholar 

Schwentner L, Helms G, Nekljudova V, Ataseven B, Bauerfeind I, Ditsch N, et al. Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trial. Breast Edinb Scotl. 2017;31:202–7. https://doi.org/10.1016/j.breast.2016.11.012.

Article  Google Scholar 

Li Y-L, Wang L-Z, Shi Q-L, He Y-J, Li J-F, Zhu H-T, et al. CT Radiomics for predicting pathological complete response of axillary lymph nodes in breast cancer after neoadjuvant chemotherapy: a prospective study. Oncologist. 2023;28:e183-90. https://doi.org/10.1093/oncolo/oyad010.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Cao W, Liu L, Meng Z, Sun N, Meng Y, et al. Noninvasive prediction of node-positive breast cancer response to presurgical neoadjuvant chemotherapy therapy based on machine learning of axillary lymph node ultrasound. J Transl Med. 2023;21:337. https://doi.org/10.1186/s12967-023-04201-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu T, Huang Y-H, Li W, Zhang Y-M, Lin Y-Y, Cheng M-Y, et al. Multi-factor artificial intelligence model assists axillary lymph node surgery in breast cancer after neoadjuvant chemotherapy: multicenter retrospective cohort study. Int J Surg Lond Engl. 2023;109:3383–94. https://doi.org/10.1097/JS9.0000000000000621.

Article  Google Scholar 

van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, et al. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104-7. https://doi.org/10.1158/0008-5472.CAN-17-0339.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang J, Zhang H, Wang J, Pu Y, Pal NR. Feature selection using a neural network with group lasso regularization and controlled redundancy. IEEE Trans Neural Netw Learn Syst. 2021;32:1110–23. https://doi.org/10.1109/TNNLS.2020.2980383.

Article  CAS  PubMed  Google Scholar 

Kantor O, Sipsy LM, Yao K, James TA. A predictive model for axillary node pathologic complete response after neoadjuvant chemotherapy for breast cancer. Ann Surg Oncol. 2018;25:1304–11. https://doi.org/10.1245/s10434-018-6345-5.

Article  PubMed  Google Scholar 

Schipper R-J, Moossdorff M, Nelemans PJ, Nieuwenhuijzen GAP, de Vries B, Strobbe LJA, et al. A model to predict pathologic complete response of axillary lymph nodes to neoadjuvant chemo(immuno)therapy in patients with clinically node-positive breast cancer. Clin Breast Cancer. 2014;14:315–22. https://doi.org/10.1016/j.clbc.2013.12.015.

Article  CAS  PubMed  Google Scholar 

Rossi S, Basso M, Strippoli A, Dadduzio V, Cerchiaro E, Barile R, et al. Hormone receptor status and HER2 expression in primary breast cancer compared with synchronous axillary metastases or recurrent metastatic disease. Clin Breast Cancer. 2015;15:307–12. https://doi.org/10.1016/j.clbc.2015.03.010.

Article  CAS  PubMed  Google Scholar 

Huang Y, Zhu T, Zhang X, Li W, Zheng X, Cheng M, et al. Longitudinal MRI-based fusion novel model predicts pathological complete response in breast cancer treated with neoadjuvant chemotherapy: a multicenter, retrospective study. eClinicalMedicine. 2023;58:101899. https://doi.org/10.1016/j.eclinm.2023.101899.

Article  PubMed  PubMed Central  Google Scholar 

Venturella R, Lico D, Sarica A, Falbo MP, Gulletta E, Morelli M, et al. OvAge: a new methodology to quantify ovarian reserve combining clinical, biochemical and 3D-ultrasonographic parameters. J Ovarian Res. 2015;8:21. https://doi.org/10.1186/s13048-015-0149-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mao N, Shi Y, Lian C, Wang Z, Zhang K, Xie H, Zhang H, Chen Q, Cheng G, Cong Xu, Dai Yi. Intratumoral and peritumoral radiomics for preoperative prediction of neoadjuvant chemotherapy effect in breast cancer based on contrast-enhanced spectral mammography. Eur Radiol. 2022;32(5):3207–19.

Article  CAS  PubMed  Google Scholar 

Demircioğlu A. The effect of preprocessing filters on predictive performance in radiomics. Eur Radiol Exp. 2022;6:40. https://doi.org/10.1186/s41747-022-00294-w.

Article  PubMed  PubMed Central  Google Scholar 

Guyon I, Gunn S, Hur AB, Dror G. Result analysis of the NIPS 2003 feature selection challenge. Proc. 17th Int. Conf. Neural Inf. Process. Syst. Cambridge: MIT Press; 2004. p. 545–52.

Google Scholar 

Demircioğlu A. Benchmarking feature selection methods in radiomics. Invest Radiol. 2022;57:433–43. https://doi.org/10.1097/RLI.0000000000000855.

Article  PubMed  Google Scholar 

Chen W, Li F-X, Lu D-L, Jiang J, Li J. Differences between the efficacy of HER2(2+)/FISH-positive and HER2(3+) in breast cancer during dual-target neoadjuvant therapy. Breast Edinb Scotl. 2023;71:69–73. https://doi.org/10.1016/j.breast.2023.07.008.

Article  Google Scholar 

Atallah NM, Alsaleem M, Toss MS, Mongan NP, Rakha E. Differential response of HER2-positive breast cancer to anti-HER2 therapy based on HER2 protein expression level. Br J Cancer. 2023. https://doi.org/10.1038/s41416-023-02426-4.

Zheng X, Yao Z, Huang Y, Yu Y, Wang Y, Liu Y, et al. Deep learning radiomics can predict axillary lymph node status in early-stage breast cancer. Nat Commun. 2020;11:1236. https://doi.org/10.1038/s41467-020-15027-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gu J, Tong T, Xu D, Cheng F, Fang C, He C, et al. Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: a multicenter study. Cancer. 2023;129:356–66. https://doi.org/10.1002/cncr.34540.

Article  CAS  PubMed  Google Scholar